...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.
【24h】

Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients.

机译:Tiam1在肝细胞癌中的过表达预示了HCC患者的预后不良。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Little research has been done to test the usefulness of T-lymphoma invasion and metastasis 1 (Tiam1) as a prognostic marker for hepatocellular carcinoma (HCC). In this study, we investigated Tiam1 expression and its prognostic value for HCC. HCC surgical tissue samples were taken from 152 HCC patients who had been followed up for 5 years. Overexpression of Tiam1 (Tiam1 2+ to 3+) was shown in 63.8% of the cases. The Tiam1 expression level did not correlate with any clinicopathological parameters. However, survival analysis showed that the Tiam1 overexpression group had a significantly shorter overall survival time than the Tiam1 downexpression group (p=0.008). Multivariate analysis showed that Tiam1 expression was a significant and independent prognostic parameter (p=0.042) for HCC patients. Tiam1 expression may be a novel and independent predictor for the prognosis of HCC patients.
机译:很少有研究来测试T淋巴瘤侵袭和转移1(Tiam1)作为肝细胞癌(HCC)的预后指标的作用。在这项研究中,我们调查了Tiam1的表达及其对肝癌的预后价值。 HCC手术组织样本取自152名HCC患者,随访了5年。 63.8%的病例显示Tiam1过表达(Tiam1 2+至3+)。 Tiam1表达水平与任何临床病理参数无关。然而,生存分析表明,Tiam1过表达组的总生存时间明显少于Tiam1下表达组(p = 0.008)。多变量分析表明,对于肝癌患者,Tiam1表达是重要且独立的预后参数(p = 0.042)。 Tiam1表达可能是HCC患者预后的一种新颖且独立的预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号